Reaction
Administration Site Bruise reporting signals
As of the last recalculation, Administration Site Bruise appears in 333 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ALIROCUMAB (PRR 44.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alirocumab | 17 | 44.6 | 44.6 |
| Botulinum Toxin Type A | 4 | 20.4 | 20.4 |